Amgen

Amgen· Health · 7 sources · Sep 1, 2026Story

UK regulator to phase out Tavneos after finding trial data unreliable

Britain's MHRA suspended the use and sale of Tavneos (Avacopan Vifor) for new patients after deeming the pivotal trial data unreliable, with a six-month window for continuing treatment and a planned UK market revocation by March 1, 2027. Amgen and CSL Vifor dispute the decision, arguing that the broader evidence supports the drug's benefits, while regulators in the EU and US have also flagged concerns about data reliability and potential withdrawals.

Health· Sep 1, 2026

+3

Amgen· Business · 6 sources · Jul 24, 2026Story

Vir Biotechnology appoints Brent Sabatini Interim CFO

Vir Biotechnology named Brent Sabatini as interim principal financial officer after Jason O’Byrne’s departure, with O’Byrne remaining through August 3 to ensure a smooth transition and a search for a permanent CFO underway. Sabatini, currently SVP and Chief Accounting Officer, brings more than two decades of finance and accounting experience and is expected to maintain continuity in financial oversight during the leadership change.

Business· Jul 24, 2026

0

Amgen· Business · 5 sources · Jul 22, 2026Story

Triad Expands Stakes Across Allstate, MediaAlpha, Visa, Amgen

Triad Investment Management expanded its holdings across a range of companies in the first quarter, purchasing additional shares in Allstate, MediaAlpha, Visa, and Amgen. The MediaAlpha position is particularly sizable among its new and increased stakes, underscoring a broad, diversified approach across financial services, advertising tech, payments, and biotech sectors.

Business· Jul 22, 2026

0

Amgen· Business · 9 sources · Jul 22, 2026Story

Danica Pension Buys New AMD Stake Worth $38M

Danica Pension Livsforsikringsaktieselskab disclosed new investments in five companies in the first quarter, taking new positions in AMD, McDonald’s, GE Vernova, Amgen, and Accenture. The moves occur amid broader institutional activity in these stocks as other investors adjust their holdings.

Business· Jul 22, 2026

0

Amgen

UK regulator to phase out Tavneos after finding trial data unreliable

Vir Biotechnology appoints Brent Sabatini Interim CFO

Triad Expands Stakes Across Allstate, MediaAlpha, Visa, Amgen

Danica Pension Buys New AMD Stake Worth $38M

Amgen

UK regulator to phase out Tavneos after finding trial data unreliable

Vir Biotechnology appoints Brent Sabatini Interim CFO

Triad Expands Stakes Across Allstate, MediaAlpha, Visa, Amgen

Danica Pension Buys New AMD Stake Worth $38M

Amgen across IJR

Related journals

Amgen across IJR

Últimas noticias y debate sobre Amgen

UK regulator to phase out Tavneos after finding trial data unreliable

Vir Biotechnology appoints Brent Sabatini Interim CFO

Triad Expands Stakes Across Allstate, MediaAlpha, Visa, Amgen

Danica Pension Buys New AMD Stake Worth $38M

Últimas noticias y debate sobre Amgen

UK regulator to phase out Tavneos after finding trial data unreliable

Vir Biotechnology appoints Brent Sabatini Interim CFO

Triad Expands Stakes Across Allstate, MediaAlpha, Visa, Amgen

Danica Pension Buys New AMD Stake Worth $38M

Amgen across IJR

Related journals

Amgen across IJR